Clinical Trial Update: ETHAN - ET for Male BC [Phase 2]

View source ↗

Summary

A Phase 2 trial named ETHAN is evaluating an ET-based therapy for male breast cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer Hormone Receptor-negative
• Breast Cancer Hormone Receptor-positive
• Male Breast Cancer

Snippet

Sponsor: Jose Pablo Leone | Conditions: Male Breast Cancer, Hormone Receptor-positive Breast Cancer | Phase 2 | Status: RECRUITING